100 related articles for article (PubMed ID: 2465278)
1. Anti-tumor and differentiation-inducing activity of N,N-dimethylformamide (DMF) in head-and-neck cancer xenografts.
van Dongen GA; Braakhuis BJ; Leyva A; Hendriks HR; Kipp BB; Bagnay M; Snow GB
Int J Cancer; 1989 Feb; 43(2):285-92. PubMed ID: 2465278
[TBL] [Abstract][Full Text] [Related]
2. Activity of differentiation-inducing agents and conventional drugs in head and neck cancer xenografts.
van Dongen G; Braakhuis BJ; Bagnay M; Leyva A; Snow GB
Acta Otolaryngol; 1988; 105(5-6):488-93. PubMed ID: 2456664
[TBL] [Abstract][Full Text] [Related]
3. Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.
Braakhuis BJ; van Dongen GA; Bagnay M; van Walsum M; Snow GB
Head Neck; 1989; 11(6):511-5. PubMed ID: 2584006
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
5. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells.
Li XN; Du ZW; Huang Q; Wu JQ
Neurosurgery; 1997 Jun; 40(6):1250-8; discussion 1258-9. PubMed ID: 9179899
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts.
Braakhuis BJ; van Dongen GA; Peters GJ; van Walsum M; Snow GB
Cancer Lett; 1990 Feb; 49(2):133-7. PubMed ID: 2306706
[TBL] [Abstract][Full Text] [Related]
8. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
9. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer.
Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ
In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck.
Rupniak HT; Rowlatt C; Lane EB; Steele JG; Trejdosiewicz LK; Laskiewicz B; Povey S; Hill BT
J Natl Cancer Inst; 1985 Oct; 75(4):621-35. PubMed ID: 2413234
[TBL] [Abstract][Full Text] [Related]
11. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region.
Elprana D; Kuijpers W; Wessels JM; Wagener DJ; van den Broek P
Anticancer Res; 1992; 12(6B):2229-39. PubMed ID: 1284201
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma.
Fujita K; Sano D; Kimura M; Yamashita Y; Kawakami M; Ishiguro Y; Nishimura G; Matsuda H; Tsukuda M
Oncol Rep; 2007 Jul; 18(1):47-51. PubMed ID: 17549344
[TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M
Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural evidence of dimethylformamide-induced differentiation of cultured human colon carcinoma cells. Increased expression of desmosomes.
Christensen TG; Burke B; Dexter DL; Zamcheck N
Cancer; 1985 Oct; 56(7):1559-65. PubMed ID: 4027892
[TBL] [Abstract][Full Text] [Related]
17. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
[TBL] [Abstract][Full Text] [Related]
18. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
[TBL] [Abstract][Full Text] [Related]
19. Growth characteristics of head and neck squamous cell carcinoma in nude mice.
Elprana D; Kuijpers W; Van den Broek P; Wagener DJ
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1211-22. PubMed ID: 3816913
[TBL] [Abstract][Full Text] [Related]
20. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
